Literature DB >> 14572444

Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice.

Estelle Rousselet1, Chantal Joubert, Jacques Callebert, Karine Parain, Léon Tremblay, Gaël Orieux, Jean-Marie Launay, Charles Cohen-Salmon, Etienne C Hirsch.   

Abstract

Behavioral analyses of mice intoxicated by the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) have generated conflicting results. We therefore analyzed the relationship between behavioral changes, loss of monoamine levels, and loss of dopaminergic cell bodies in groups of mice intoxicated with acute or subchronic MPTP protocols. Despite a higher degree of neuronal loss in the mice intoxicated using subchronic protocols, dopamine loss was severe and homogeneous in the striatum in all groups. Dopamine levels were less severely reduced in the frontal cortex in the three groups of MPTP-intoxicated mice. Norepinephrine and serotonin levels in the striatum were decreased only in the mice intoxicated with the acute protocol. The most surprising result was that the mice intoxicated with the subchronic protocols were more active than the saline-treated mice. As reported in rats with dopamine depletion in the prefrontal cortex, the hyperactivity observed in our mice could be due to the reduced dopamine levels detected in this structure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572444     DOI: 10.1016/s0969-9961(03)00108-6

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

1.  5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Authors:  Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch; Twum A Ansah
Journal:  Neuropharmacology       Date:  2010-03-31       Impact factor: 5.250

2.  MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.

Authors:  Panchanan Maiti; Laura C Gregg; Michael P McDonald
Journal:  Behav Brain Res       Date:  2015-09-21       Impact factor: 3.332

3.  A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice.

Authors:  Megan N Roberts; Marita A Wallace; Alexey A Tomilov; Zeyu Zhou; George R Marcotte; Dianna Tran; Gabriella Perez; Elena Gutierrez-Casado; Shinichiro Koike; Trina A Knotts; Denise M Imai; Stephen M Griffey; Kyoungmi Kim; Kevork Hagopian; Marissa Z McMackin; Fawaz G Haj; Keith Baar; Gino A Cortopassi; Jon J Ramsey; Jose Alberto Lopez-Dominguez
Journal:  Cell Metab       Date:  2017-09-05       Impact factor: 27.287

4.  Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease.

Authors:  Mark McCollum; Zhiyuan Ma; Eric Cohen; Rebecca Leon; Rui Tao; Jang-Yen Wu; Dipnarine Maharaj; Jianning Wei
Journal:  Mol Neurobiol       Date:  2010-04-21       Impact factor: 5.590

5.  Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.

Authors:  A Ostergren; A Fredriksson; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

6.  Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.

Authors:  Gulnara R Khakimova; Elena A Kozina; Valerian G Kucheryanu; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2016-05-19       Impact factor: 5.590

7.  Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene.

Authors:  Heather A Boger; Lawrence D Middaugh; Vandana Zaman; Barry Hoffer; Ann-Charlotte Granholm
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

Review 8.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

9.  Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.

Authors:  Tultul Nayyar; Michael Bubser; Marcus C Ferguson; M Diana Neely; J Shawn Goodwin; Thomas J Montine; Ariel Y Deutch; Twum A Ansah
Journal:  Eur J Neurosci       Date:  2009-07       Impact factor: 3.386

10.  Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.

Authors:  K S Rommelfanger; G L Edwards; K G Freeman; L C Liles; G W Miller; D Weinshenker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.